Centre For Orthopaedics Rehabilitation & Allied Sciences (Coras) Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 25-12-2024
- Paid Up Capital ₹ 0.10 M
as on 25-12-2024
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2019)
- Net Worth -52.96%
(FY 2019)
- Total Assets -0.01%
(FY 2019)
About Centre For Orthopaedics Rehabilitation & Allied Sciences (Coras)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pranjal Mahanta, Diganta Phukan, Iran Bharali, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110AS2014PTC011811
- Company No.
011811
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Mar 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Kamrup, Assam, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Centre For Orthopaedics Rehabilitation & Allied Sciences (Coras)?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pranjal Mahanta  | Director | 03-Mar-2014 | Current |
| Diganta Phukan | Director | 03-Mar-2014 | Current |
| Iran Bharali | Director | 03-Mar-2014 | Current |
| Jintu Borah | Director | 03-Mar-2014 | Current |
Financial Performance of Centre For Orthopaedics Rehabilitation & Allied Sciences (Coras).
Centre For Orthopaedics Rehabilitation & Allied Sciences (Coras) Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 52.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Centre For Orthopaedics Rehabilitation & Allied Sciences (Coras)?
In 2018, Centre For Orthopaedics Rehabilitation & Allied Sciences (Coras) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Centre For Orthopaedics Rehabilitation & Allied Sciences (Coras)?
Unlock and access historical data on people associated with Centre For Orthopaedics Rehabilitation & Allied Sciences (Coras), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Centre For Orthopaedics Rehabilitation & Allied Sciences (Coras), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Centre For Orthopaedics Rehabilitation & Allied Sciences (Coras)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
